Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
Remdesivir is under evaluation for treatment of COVID-19 in clinical trials. Here, the authors report results of remdesivir treatment in a patient with COVID-19 and the genetic antibody deficiency XLA. They show a temporally correlated clinical and virological response, suggesting that remdesivir ca...
Guardado en:
Ejemplares similares
-
Analysis of temporal trends in potential COVID-19 cases reported through NHS Pathways England
por: Quentin J. Leclerc, et al.
Publicado: (2021) -
COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
por: Carl A B Pearson, et al.
Publicado: (2021) -
Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studies [version 2; peer review: 3 approved]
por: Eleanor M. Rees, et al.
Publicado: (2021) -
Novel Concepts for HIV Vaccine Vector Design
por: Quazim A. Alayo, et al.
Publicado: (2017) -
Water quality improvements offset the climatic debt for stream macroinvertebrates over twenty years
por: Ian P. Vaughan, et al.
Publicado: (2019)